The average selling price for ENDURITY in South Korea dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the ENDURITY device in South Korea can be viewed in GlobalData’s micro pricing report. Buy the report here.
The ENDURITY is sold by Abbott Laboratories in the Single Chamber Pacemakers market. Single chamber pacemakers are devices which have a single pacing lead placed into a chamber of the heart. This could be the atrium or ventricle.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Abbott Laboratories’ Single Chamber Pacemakers device pricing in South Korea, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.